Related Experiment Videos
Optimizing adaptive design for Phase 2 dose-finding trials incorporating long-term success and financial
Jingjing Gao1, Narinder Nangia2, Jia Jia1
1Abbvie Inc., North Chicago, IL, USA.
Contemporary Clinical Trials
|April 8, 2017
Abstract:
In this paper, we propose an adaptive randomization design for Phase 2 dose-finding trials to optimize Net Present Value (NPV) for an experimental drug. We replace the traditional fixed sample size design (Patel, et al., 2012) by this new design to see if NPV from the original paper can be improved. Comparison of the proposed design to the previous design is made via simulations using a hypothetical example based on a Diabetic Neuropathic Pain Study.